Related Experiment Video
Updated: Jun 15, 2026
09:06
Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
Gabapentin enacarbil in restless legs syndrome
Giovanni Merlino1, Anna Serafini, Simone Lorenzut
1Sleep Disorders Center, Dept. of Neurosciences, Santa Maria della Misericordia University Hospital, Udine, Italy. gigli@uniud.it
Drugs of Today (Barcelona, Spain : 1998)
|March 5, 2010
Summary
Gabapentin enacarbil effectively treats restless legs syndrome (RLS) with doses of 1200-1800 mg/day. Side effects like dizziness are mild and temporary, warranting further long-term studies.
Area of Science:
- Neurology
- Pharmacology
Background:
- Restless legs syndrome (RLS) is a common sleep disorder.
- Severe RLS may lead to comorbidities like psychological distress and cardiovascular issues.
- Dopamine agonists are first-line RLS treatments, but adverse events necessitate alternatives.
Purpose of the Study:
- To evaluate the efficacy and safety of gabapentin enacarbil for treating restless legs syndrome (RLS).
Main Methods:
- Gabapentin enacarbil, a prodrug of gabapentin, was developed to improve pharmacokinetic properties.
- An extended-release formulation was utilized.
- Doses ranged from 1200 to 1800 mg/day.
Main Results:
- Gabapentin enacarbil demonstrated dose-proportional exposure without saturation.
- Effective RLS treatment was observed within days at doses of 1200-1800 mg/day.
- Common adverse events included mild, transient dizziness and somnolence.
Conclusions:
- Gabapentin enacarbil shows promise as an effective RLS treatment with a favorable short-term safety profile.
- Further research is needed to confirm long-term efficacy and safety.
- The extended-release formulation offers characteristics of optimal drug therapy.
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...